APO RESEARCH · REPORT
E-Prescribing System
E-prescribing or electronic prescribing is a process involving the electronic generation and sending of prescription orders for the convenience of medical practitioners or physicians, allowing them to transmit prescriptions directly from the point of care to a pharmacy. E-prescribing enhances the safety of patients and the quality of care, since there is no manual writing involved and thus there is less probability of prescription errors. In addition, e-prescribing also helps conduct security checks, encapsulate medical lists, and compile the complete historical data of a patient.
Product & engineering
Understand the product.
E-prescribing or electronic prescribing is a process involving the electronic generation and sending of prescription orders for the convenience of medical practitioners or physicians, allowing them to transmit prescriptions directly from the point of care to a pharmacy. E-prescribing enhances the safety of patients and the quality of care, since there is no manual writing involved and thus there is less probability of prescription errors. In addition, e-prescribing also helps conduct security checks, encapsulate medical lists, and compile the complete historical data of a patient.
Selected research
Market Outlook & Growth Opportunities
Global E-Prescribing System Market Outlook and Growth Opportunities 2026
Market perspective
E-prescribing or electronic prescribing is a process involving the electronic generation and sending of prescription orders for the convenience of medical practitioners or physicians, allowing them to transmit prescriptions directly from the point of care to a pharmacy. E-prescribing enhances the safety of patients and the quality of care, since there is no manual writing involved and thus there is less probability of prescription errors. In addition, e-prescribing also helps conduct security checks, encapsulate medical lists, and compile the complete historical data of a patient.
Major participants in the Global Electronic Prescription System are Surescripts, Henry Schein, Cerner Corporation, HealthFusion, Allscripts, Athenahealth, Bizmatics, eClinicalWorks and Medi-Her, among others.
This report provides an overview of the global E-Prescribing System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of E-Prescribing System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents E-Prescribing System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global E-Prescribing System market.
E-Prescribing System Segment by Company
Surescripts
Henry Schein
Cerner Corporation
HealthFusion
Allscripts
Athenahealth
Bizmatics
EClinicalWorks
Medi-HER
Practice Fusion
DrFirst
E-Prescribing System Segment by Type
Stand-Alone Systems
Integrated Systems
E-Prescribing System Segment by Application
Hospitals
Office-Based Physicians
E-Prescribing System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global E-Prescribing System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the E-Prescribing System key companies, revenue, market share, and recent developments.
3. To split the E-Prescribing System breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions E-Prescribing System market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify E-Prescribing System significant trends, drivers, influence factors in global and regions.
6. To analyze E-Prescribing System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global E-Prescribing System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of E-Prescribing System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of E-Prescribing System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global E-Prescribing System industry.
Chapter 3: Detailed analysis of E-Prescribing System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of E-Prescribing System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of E-Prescribing System in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Stand-Alone Systems
- Integrated Systems
Applications
- Hospitals
- Office-Based Physicians
Companies covered
- Surescripts
- Henry Schein
- Cerner Corporation
- HealthFusion
- Allscripts
- Athenahealth
- Bizmatics
- EClinicalWorks
- Medi-HER
- Practice Fusion
- DrFirst
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global E-Prescribing System Market Size, 2021 VS 2025 VS 2032
- 1.3 Global E-Prescribing System Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 E-Prescribing System Market Dynamics
- 2.1 E-Prescribing System Industry Trends
- 2.2 E-Prescribing System Industry Drivers
- 2.3 E-Prescribing System Industry Opportunities and Challenges
- 2.4 E-Prescribing System Industry Restraints
3 E-Prescribing System Market by Company
- 3.1 Global E-Prescribing System Company Revenue Ranking in 2025
- 3.2 Global E-Prescribing System Revenue by Company (2021-2026)
- 3.3 Global E-Prescribing System Company Ranking (2024-2026)
- 3.4 Global E-Prescribing System Company Manufacturing Base and Headquarters
- 3.5 Global E-Prescribing System Company Product Type and Application
- 3.6 Global E-Prescribing System Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global E-Prescribing System Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 E-Prescribing System Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 E-Prescribing System Market by Type
- 4.1 E-Prescribing System Type Introduction
- 4.1.1 Stand-Alone Systems
- 4.1.2 Integrated Systems
- 4.2 Global E-Prescribing System Sales Value by Type
- 4.2.1 Global E-Prescribing System Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global E-Prescribing System Sales Value by Type (2021-2032)
- 4.2.3 Global E-Prescribing System Sales Value Share by Type (2021-2032)
5 E-Prescribing System Market by Application
- 5.1 E-Prescribing System Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Office-Based Physicians
- 5.2 Global E-Prescribing System Sales Value by Application
- 5.2.1 Global E-Prescribing System Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global E-Prescribing System Sales Value by Application (2021-2032)
- 5.2.3 Global E-Prescribing System Sales Value Share by Application (2021-2032)
6 E-Prescribing System Regional Value Analysis
- 6.1 Global E-Prescribing System Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global E-Prescribing System Sales Value by Region (2021-2032)
- 6.2.1 Global E-Prescribing System Sales Value by Region: 2021-2026
- 6.2.2 Global E-Prescribing System Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America E-Prescribing System Sales Value (2021-2032)
- 6.3.2 North America E-Prescribing System Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe E-Prescribing System Sales Value (2021-2032)
- 6.4.2 Europe E-Prescribing System Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific E-Prescribing System Sales Value (2021-2032)
- 6.5.2 Asia-Pacific E-Prescribing System Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America E-Prescribing System Sales Value (2021-2032)
- 6.6.2 South America E-Prescribing System Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa E-Prescribing System Sales Value (2021-2032)
- 6.7.2 Middle East & Africa E-Prescribing System Sales Value Share by Country, 2025 VS 2032
7 E-Prescribing System Country-level Value Analysis
- 7.1 Global E-Prescribing System Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global E-Prescribing System Sales Value by Country (2021-2032)
- 7.2.1 Global E-Prescribing System Sales Value by Country (2021-2026)
- 7.2.2 Global E-Prescribing System Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.3.2 USA E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.7.2 France E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.14.2 China E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.17.2 India E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran E-Prescribing System Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt E-Prescribing System Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt E-Prescribing System Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt E-Prescribing System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Surescripts
- 8.1.1 Surescripts Company Information
- 8.1.2 Surescripts Business Overview
- 8.1.3 Surescripts E-Prescribing System Revenue and Gross Margin (2021-2026)
- 8.1.4 Surescripts E-Prescribing System Product Portfolio
- 8.1.5 Surescripts Recent Developments
- 8.2 Henry Schein
- 8.2.1 Henry Schein Company Information
- 8.2.2 Henry Schein Business Overview
- 8.2.3 Henry Schein E-Prescribing System Revenue and Gross Margin (2021-2026)
- 8.2.4 Henry Schein E-Prescribing System Product Portfolio
- 8.2.5 Henry Schein Recent Developments
- 8.3 Cerner Corporation
- 8.3.1 Cerner Corporation Company Information
- 8.3.2 Cerner Corporation Business Overview
- 8.3.3 Cerner Corporation E-Prescribing System Revenue and Gross Margin (2021-2026)
- 8.3.4 Cerner Corporation E-Prescribing System Product Portfolio
- 8.3.5 Cerner Corporation Recent Developments
- 8.4 HealthFusion
- 8.4.1 HealthFusion Company Information
- 8.4.2 HealthFusion Business Overview
- 8.4.3 HealthFusion E-Prescribing System Revenue and Gross Margin (2021-2026)
- 8.4.4 HealthFusion E-Prescribing System Product Portfolio
- 8.4.5 HealthFusion Recent Developments
- 8.5 Allscripts
- 8.5.1 Allscripts Company Information
- 8.5.2 Allscripts Business Overview
- 8.5.3 Allscripts E-Prescribing System Revenue and Gross Margin (2021-2026)
- 8.5.4 Allscripts E-Prescribing System Product Portfolio
- 8.5.5 Allscripts Recent Developments
- 8.6 Athenahealth
- 8.6.1 Athenahealth Company Information
- 8.6.2 Athenahealth Business Overview
- 8.6.3 Athenahealth E-Prescribing System Revenue and Gross Margin (2021-2026)
- 8.6.4 Athenahealth E-Prescribing System Product Portfolio
- 8.6.5 Athenahealth Recent Developments
- 8.7 Bizmatics
- 8.7.1 Bizmatics Company Information
- 8.7.2 Bizmatics Business Overview
- 8.7.3 Bizmatics E-Prescribing System Revenue and Gross Margin (2021-2026)
- 8.7.4 Bizmatics E-Prescribing System Product Portfolio
- 8.7.5 Bizmatics Recent Developments
- 8.8 EClinicalWorks
- 8.8.1 EClinicalWorks Company Information
- 8.8.2 EClinicalWorks Business Overview
- 8.8.3 EClinicalWorks E-Prescribing System Revenue and Gross Margin (2021-2026)
- 8.8.4 EClinicalWorks E-Prescribing System Product Portfolio
- 8.8.5 EClinicalWorks Recent Developments
- 8.9 Medi-HER
- 8.9.1 Medi-HER Company Information
- 8.9.2 Medi-HER Business Overview
- 8.9.3 Medi-HER E-Prescribing System Revenue and Gross Margin (2021-2026)
- 8.9.4 Medi-HER E-Prescribing System Product Portfolio
- 8.9.5 Medi-HER Recent Developments
- 8.10 Practice Fusion
- 8.10.1 Practice Fusion Company Information
- 8.10.2 Practice Fusion Business Overview
- 8.10.3 Practice Fusion E-Prescribing System Revenue and Gross Margin (2021-2026)
- 8.10.4 Practice Fusion E-Prescribing System Product Portfolio
- 8.10.5 Practice Fusion Recent Developments
- 8.11 DrFirst
- 8.11.1 DrFirst Company Information
- 8.11.2 DrFirst Business Overview
- 8.11.3 DrFirst E-Prescribing System Revenue and Gross Margin (2021-2026)
- 8.11.4 DrFirst E-Prescribing System Product Portfolio
- 8.11.5 DrFirst Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst